School of Acupuncture-Moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
JMIR Res Protoc. 2024 Nov 4;13:e55870. doi: 10.2196/55870.
Stress urinary incontinence (SUI), the most common form of urinary incontinence, is a condition that affects many women. It is characterized by involuntary urine leakage during activities that increase abdominal pressure, such as sneezing, coughing, or physical exertion, according to the International Continence Society. SUI affects patients' quality of life and causes depression and emotional disorders, which negatively influences physical and mental health. The participants in the studies in this review comprised women with mild to moderate SUI, because there are more female patients than male patients, and most patients with severe SUI are treated surgically. Moreover, after retrieval, there were no systematic reviews or network meta-analyses (NMAs) of conservative treatments, such as electroacupuncture (EA), in women with mild to moderate SUI.
This study aims to investigate the efficacy of electroacupuncture among women with mild to moderate SUI using an NMA.
Randomized clinical trials related to conservative treatments for SUI will be searched in 5 English and 3 Chinese literature databases: EMBASE, PubMed, Cochrane, Web of Science, ClinicalTrials.gov, Chinese National Knowledge Infrastructure (CNKI), WanFang, and the Chinese BioMedical Literature Database. The search period for these 8 electronic databases will be from 2002 to 2022. The PROSPERO database and the International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) database will also be searched. Two reviewers will independently complete the research selection. After screening the studies, 2 other researchers will extract the data, and the quality of the included studies will be evaluated according to the quality standards specified in the Cochrane Collaboration Tool (version 2). The primary outcomes will be the change in urine leakage determined by a 1-hour pad test and International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) scores at baseline and at the conclusion of the follow-up. The secondary outcomes will be 72-hour incontinence episodes, residual bladder volume, effective rate, urodynamic indexes, and other reported measurements. Stata (version 14.0; StataCorp) and Review Manager (RevMan version 5.3; Cochrane) will be implemented for data synthesis and meta-analysis.
The results are not yet accessible because this is a protocol for a systematic review and meta-analysis. The protocol was registered on INPLASY on February 22, 2023. By April 6, 2023, we had completed the literature search of the 8 databases and completed the selection and data extraction of the articles.
The results of this systematic review will demonstrate the efficacy of EA among women with mild to moderate SUI. The results will provide evidence for clinicians and guideline makers to choose suitable treatments for SUI.
International Platform of Registered Systematic Review and Meta-Analysis Protocols (INPLASY) 202320098; https://inplasy.com/inplasy-2023-2-0098/.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/55870.
压力性尿失禁(SUI)是最常见的尿失禁形式,影响着许多女性。根据国际尿控协会的定义,SUI 是指在增加腹压的活动中(如打喷嚏、咳嗽或体力活动)出现不自主的尿液漏出。SUI 会降低患者的生活质量,并导致抑郁和情绪障碍,从而对身心健康产生负面影响。本综述研究的参与者包括患有轻至中度 SUI 的女性,因为女性患者多于男性患者,大多数患有严重 SUI 的患者都接受手术治疗。此外,检索后发现,对于轻至中度 SUI 女性,没有关于电针(EA)等保守治疗的系统评价或网络荟萃分析(NMA)。
本研究旨在通过 NMA 评估 EA 对轻至中度 SUI 女性的疗效。
将在 5 个英文数据库和 3 个中文数据库中检索与 SUI 保守治疗相关的随机临床试验:EMBASE、PubMed、Cochrane、Web of Science、ClinicalTrials.gov、中国知网(CNKI)、万方和中国生物医学文献数据库。这 8 个电子数据库的检索时间为 2002 年至 2022 年。还将检索 PROSPERO 数据库和国际注册系统评价和荟萃分析方案平台(INPLASY)数据库。两位评审员将独立完成研究选择。筛选研究后,另外两名研究人员将提取数据,并根据 Cochrane 协作工具(版本 2)中规定的质量标准评估纳入研究的质量。主要结局是 1 小时垫试验和国际尿失禁咨询问卷短表(ICIQ-SF)评分的基线和随访结束时的尿漏变化。次要结局为 72 小时尿失禁发作、残余膀胱容量、有效率、尿动力学指标和其他报告的测量值。将使用 Stata(版本 14.0;StataCorp)和 Review Manager(RevMan 版本 5.3;Cochrane)进行数据综合和荟萃分析。
由于这是一项系统评价和荟萃分析的方案,结果尚不可用。该方案于 2023 年 2 月 22 日在 INPLASY 上注册。截至 2023 年 4 月 6 日,我们已经完成了 8 个数据库的文献检索,并完成了文章的选择和数据提取。
本系统评价的结果将展示 EA 对轻至中度 SUI 女性的疗效。结果将为临床医生和指南制定者选择 SUI 的合适治疗方法提供证据。
国际注册系统评价和荟萃分析方案(INPLASY)202320098;https://inplasy.com/inplasy-2023-2-0098/。
国际注册报告标识符(IRRID):DERR1-10.2196/55870。